Detailed Information
Cited 5 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Safety and preliminary clinical activity of repotrectinib in patients with advanced ROS1/TRK fusion-positive solid tumors (TRIDENT-1 study)444PD - Safety and preliminary clinical activity of repotrectinib in patients with advanced ROS1/TRK fusion-positive solid tumors (TRIDENT-1 study)
- Other Titles
- 444PD - Safety and preliminary clinical activity of repotrectinib in patients with advanced ROS1/TRK fusion-positive solid tumors (TRIDENT-1 study)
- Authors
- Drilon, A[Drilon, A.]; Cho, BC[Cho, B. C.]; Kim, DW[Kim, D. -W.]; Lee, J[Lee, J.]; Lin, JJ[Lin, J. J.]; Zhu, V[Zhu, V.]; Camidge, RD[Camidge, R. D.]; Stopatschinskaja, S[Stopatschinskaja, S.]; Cui, JJ[Cui, J. J.]; Hyman, DM[Hyman, D. M.]; Ou, SH[Ou, S. -H.]; Shaw, AT[Shaw, A. T.]; Doebele, RC[Doebele, R. C.]
- Issue Date
- Oct-2019
- Publisher
- OXFORD UNIV PRESS
- Citation
- ANNALS OF ONCOLOGY, v.30, no.5, pp.v162 - v162
- Indexed
- SCIE
SCOPUS
- Journal Title
- ANNALS OF ONCOLOGY
- Volume
- 30
- Number
- 5
- Start Page
- v162
- End Page
- v162
- ISSN
- 0923-7534
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.